Brief: Nemaura Medical Submits Premarket Approval Application For Sugarbeat® To U.S. FDA
07/07/2020 11:24
July 7 (Reuters) - Nemaura Medical Inc NMRD.O :
* NEMAURA MEDICAL SUBMITS PMA APPLICATION FOR SUGARBEAT® TO
U.S.
FDA
Source text for Eikon: ID:nBw2YJyl5a
Further company coverage: NMRD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nemaura Medical
See all newsBrief: Nemaura Medical To Move To OTC Markets
U.S. RESEARCH ROUNDUP- Ameren Corp, Bread Financial Holdings, Exelon Corp
Brief: Nemaura Medical Receives Positive Nasdaq Listing Decision
Brief: Nemaura Medical Secures $10 Mln Non-Dilutive Credit Facility
Brief: Nemaura Launches Direct To Consumer Offering Of Metabolic Health Program